Medical device companies pay physicians 7 times more than drug companies do, study finds

New York : Compared to pharmaceutical companies, medical device and supply companies pay seven times more of their total industry revenue to physicians, according to a study published April 5 in Health Affairs.

Many physicians receive payments from medical device companies that make products physicians can use or recommend. The payments are controversial because of concerns they may influence physicians to use certain devices for patients even if they’re not the best option, the study’s authors wrote.

The study, conducted by researchers at the University of Pennsylvania in Philadelphia and Columbia Business School in New York City, analyzed data by payment type, physician specialty and Medicare billing amount.

Between 2014 and 2017, medical device vendors paid $904 million to 196,624 physicians per year on average, the study found.

During the same time period, pharmaceutical vendors paid $821 million to 331,187 physicians.

Though the dollar amounts are similar, the pharmaceutical industry is much larger than the device industry, the researchers noted. Device companies also paid larger amounts to fewer physicians.

Payments to physicians represented about 1.7 percent of device industry revenue, more than seven times the 0.24 percent of pharmaceutical industry revenue spent on physician payments.

The top-paying device vendor was Medtronic, followed by Johnson & Johnson and Zimmer Biomet.

The payments were highly targeted to high-billing physicians in surgical specialties, the researchers wrote.

The authors noted that the study was limited to physicians participating in Medicare.

  • Related Posts

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    GUWAHATI: Indian Institute of Technology Guwahati researchers have developed an optical sensing device that can instantly detect a variety of toxicants in water and other biological samples. Aligned with the Government…

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

    Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad